Stocks and Investing Stocks and Investing
Wed, June 14, 2023

Graig Suvannavejh Reiterated (AXSM) at Strong Buy and Held Target at $95 on, Jun 14th, 2023


Published on 2024-10-28 04:21:26 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Mizuho, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $95 on, Jun 14th, 2023.

Graig has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $90 on, Monday, June 12th, 2023


These are the ratings of the 4 analyists that currently disagree with Graig


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $200 on, Thursday, May 11th, 2023
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $100 on, Tuesday, May 9th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $104 on, Tuesday, May 9th, 2023
  • Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
Contributing Sources